23
Views
13
CrossRef citations to date
0
Altmetric
Original Research

RETRACTED ARTICLE: Long Noncoding RNA FGD5-AS1 Acts as a Competing Endogenous RNA on microRNA-383 to Enhance the Malignant Characteristics of Esophageal Squamous Cell Carcinoma by Increasing SP1 Expression

, , , &
Pages 2265-2278 | Published online: 26 Mar 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Yan Fang, Sihao Huang, Lei Han, Shuyi Wang & Bin Xiong. (2021) Comprehensive Analysis of Peritoneal Metastasis Sequencing Data to Identify LINC00924 as a Prognostic Biomarker in Gastric Cancer. Cancer Management and Research 13, pages 5599-5611.
Read now

Articles from other publishers (11)

Abdollah Jafarzadeh, Majid Noori, Shaghayegh Sarrafzadeh, Seyed Saeed Tamehri Zadeh, Maryam Nemati, Nazanin Chatrabnous, Sara Jafarzadeh, Michael R Hamblin, Mohammad Hassan Jafari Najaf Abadi & Hamed Mirzaei. (2022) MicroRNA-383: A tumor suppressor miRNA in human cancer. Frontiers in Cell and Developmental Biology 10.
Crossref
Lijuan Zhang, Xinyi Cai, Youguo Dai, Yun Chen, Jing Yu & Yongchun Zhou. (2022) Targeting the lncRNA FGD5-AS1/miR-497-5p/PD-L1 Axis Inhibits Malignant Phenotypes in Colon Cancer (CC). BioMed Research International 2022, pages 1-16.
Crossref
Chen‐Kun He, Zeng‐Bo Li, Da Yi, Xiang‐Ya Zhu, Rong‐Rong Liu, Dong‐Xin Zhang, Qian Cao & Yi‐Ping Chen. (2022) LncRNA FGD5‐AS1 enhances the proliferation and stemness of hepatocellular carcinoma cells through targeting miR‐223 and regulating the expression of ECT2 and FAT1. Hepatology Research 52:7, pages 614-629.
Crossref
Uttam Sharma, Masang Murmu, Tushar Singh Barwal, Hardeep Singh Tuli, Manju Jain, Hridayesh Prakash, Tea Kaceli, Aklank Jain & Anupam Bishayee. (2022) A Pleiotropic Role of Long Non-Coding RNAs in the Modulation of Wnt/β-Catenin and PI3K/Akt/mTOR Signaling Pathways in Esophageal Squamous Cell Carcinoma: Implication in Chemotherapeutic Drug Response. Current Oncology 29:4, pages 2326-2349.
Crossref
Jingyang Chen, Meiru Bian, Lingxiao Pan, Chengdong Liu & Hanshi Yang. (2022) GABPB1-AS1 Promotes the Development of Osteosarcoma by Targeting SP1 and Activating the Wnt/β-Catenin Pathway. Journal of Oncology 2022, pages 1-11.
Crossref
Xiao-ling Fang & Shu-guang Shi. (2022) lncRNA FGD5-AS1 acts as a ceRNA to regulate lipopolysaccharide-induced injury via the miR-223-3p-3p/GAS5 axis in cardiomyocytes. Human & Experimental Toxicology 41, pages 096032712211389.
Crossref
Yue Yang, Zhibo Sun, Feng Liu, Yuanzhang Bai & Fei Wu. (2021) FGD5-AS1 Inhibits Osteoarthritis Development by Modulating miR-302d-3p/TGFBR2 Axis. CARTILAGE 13:2_suppl, pages 1412S-1420S.
Crossref
Su-Jie Gao, Sheng-Nan Ren, Yi-Ting Liu, Hong-Wei Yan & Xue-Bo Chen. (2021) Targeting EGFR sensitizes 5-Fu-resistant colon cancer cells through modification of the lncRNA-FGD5-AS1-miR-330-3p-Hexokinase 2 axis. Molecular Therapy - Oncolytics 23, pages 14-25.
Crossref
Yating Wen, Fangzhen Luo, Lanhua Zhao, Shengmei Su, Wenbo Lei, Yi Liu, Keliang Shi & Zhongyu Li. (2021) Long Non-Coding RNA FGD5-AS1 Induced by Chlamydia trachomatis Infection Inhibits Apoptosis via Wnt/β-Catenin Signaling Pathway. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Sutpirat Moonmuang, Parunya Chaiyawat, Salinee Jantrapirom, Dumnoensun Pruksakorn & Luca Lo Piccolo. (2021) Circulating Long Non-Coding RNAs as Novel Potential Biomarkers for Osteogenic Sarcoma. Cancers 13:16, pages 4214.
Crossref
Fang Cui, Peng Luo, Yao Bai & Jiangping Meng. (2021) Silencing of Long Non-Coding RNA FGD5-AS1 Inhibits the Progression of Non-Small Cell Lung Cancer by Regulating the miR-493-5p/DDX5 Axis. Technology in Cancer Research & Treatment 20, pages 153303382199000.
Crossref